Laboratory Corp. (LH) to Acquire MEDTOX Scientific (MTOX) in $241M Deal
Tweet Send to a FriendGet Alerts LH Hot Sheet
Trade LH Now!
Laboratory Corporation of America Holdings (NYSE: LH) and MEDTOX Scientific, Inc. (Nasdaq: MTOX), a provider of high quality specialized laboratory testing services and on-site/point-of-collection testing (POCT) devices, today announced that they had entered into a definitive merger agreement under which LabCorp would acquire MEDTOX for a purchase price of $27.00 per share in cash, representing a total enterprise value of approximately $241,000,000. The board of directors of MEDTOX unanimously approved the agreement and recommended approval of the transaction by MEDTOX’s shareholders.
The transaction is subject to customary closing conditions including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and approval by MEDTOX’s stockholders. The transaction is expected to close in the third quarter of 2012.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The transaction is subject to customary closing conditions including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and approval by MEDTOX’s stockholders. The transaction is expected to close in the third quarter of 2012.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: ViroPharma (VPHM) on the Move Following Takeover Chatter - Reuters
- Huawei Has 'No Plans to Acquire Nokia' (NOK) - Bloomberg
- Orchard Supply (OSH) permitted to seek bids for store closing sales - Bloomberg
Create E-mail Alert Related Categories
Mergers and AcquisitionsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Down)